Skip to main content
. 2018 Jan 9;36(11):1128–1139. doi: 10.1200/JCO.2017.74.3179

Fig A2.

Fig A2.

Radiographic changes after infusion of dominant-negative transforming growth factor-β (TGF-β) type 2 receptor (DNRII) latent membrane protein–specific T cells (DNRII-LSTs) in patient 8. Whereas it was documented that patient 8 had stable disease overall, decreases in standardized uptake values (SUVs) were demonstrated on positron emission tomography scan within 2 months of DNRII-LST infusion, corresponding to a rise in DNRII-transduced T cells as determined by quantitative PCR.